<DOC>
	<DOCNO>NCT01612741</DOCNO>
	<brief_summary>In prospective , non interventional , observational Post Marketing Survelliance study data obtain efficacy , safety tolerability Glucobay treatment top metformin daily life treatment conditions.Specifically investigated influence Glucobay Post Prandial Blood Glucose HbA1c well pateint 's weight add already exist metformin therapy.The study plan carry 25000 - 30000 patient 200 trial site India.The PMS study perform commercially available medication prescribe within regular practice physician . No examination perform would do without Post Marketing Survelliance study .</brief_summary>
	<brief_title>Diabetes Treatment With Glucobay Combination With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>All patient type 2 diabetes one follow treatment ongoing : 1 ) Metformin 2 ) Metformin + OHA . In patient , investigator feel addition acarbose would benficial patient According local product information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Diabetes Mellitus , Type-2</keyword>
	<keyword>Acarbose</keyword>
	<keyword>Drug Therapy</keyword>
	<keyword>Combination</keyword>
</DOC>